Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles D. Scher is active.

Publication


Featured researches published by Charles D. Scher.


Nature | 1975

Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Charles D. Scher; Richard Siegler

MURINE leukaemia viruses (MLV) cause tumours of haemopoietic origin in vivo1,2, but although they replicate in vitro, they generally do not transform cells. MLV provides helper activity3 for the replication of defective murine sarcoma virus (MSV)4 which possess a transforming activity5. Abelson and Rabstein6 isolated an agent in association with Moloney leukaemia virus (MLV-M) which causes a rapidly progressive lymphoblastic leukaemia of bone-marrow-derived lymphocytes (B cells)7. In addition, this Abelson virus (MLV-A) in conjunction with MLV-M causes rapid appearance of immunoglobulin-producing plasmacytomas in BALB/c mice primed with oil8. We now report that MLV-A can be defective for virus replication and show that this agent directly transforms 3T3 cells in vitro. A quantitative transformation assay is described.


Cell | 1979

Centriole deciliation associated with the early response of 3T3 cells to growth factors but not to SV40

Robert W. Tucker; Charles D. Scher; Charles D. Stiles

Abstract BALB/c-3T3 cells which are growth-arrested by high cell density or low serum have ciliated, unduplicated centrioles. Stimulation of these quiescent cells by serum is associated with a rapid (within 1–2 hr) deciliation of the centriole, followed by reciliation within 6–10 hr. This transient deciliation of the centriole is induced by the platelet-derived growth factor (PDGF) component of serum. The cells treated with PDGF became competent to replicate their DNA; most PDGF treated cells, however, did not progress from Go toward S phase unless they were incubated with the platelet-poor plasma component of serum. Addition of CaCl 2 or Fibroblast Growth Factor to the media mimicked PDGF by producing both centriole deciliation and competence to replicate DNA. In fact, over a range of concentrations of each of these factors, only doses which produced centriole deciliation were capable of producing competence for DNA synthesis. Plasma alone or factors such as Multiplication Stimulating Activity produced neither centriole deciliation nor competence; these agents were, however, required for the optimum progression of competent cells into DNA synthesis. In contrast, infection with SV40 induced host cell DNA synthesis without an initial transient deciliation of the centriole. Thus while growth factors may have to induce centriole deciliation for 3T3 cells to synthesize DNA, abortive transformation by SV40 overrides this requirement.


Cell | 1976

The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells

Charles D. Scher; C. Haudenschild; Michael Klagsbrun

The chick chorioallantoic membrane (CAM) was used as an assay system to investigate the the invasive properties of viral transformed NIH/3Y3 cells. Scanning electron microscopy demonstrated that single Kirsten sarcoma virus (KiSV)-transformed cells passed between the epithelial cells of the CAM ectoderm within 6 hr of application, while viable NIH/3T3 cells did not penetrate the ectoderm within 24 hr. The transformed cells entered the mesoderm of the CAM and formed tumors of proliferating cells. The application of 5 X 10(5) KiSV-transformed cells resulted in the formation of donor cells resulted in the formation of the donor cell tumors within 5 days in 43% of the membranes. No tumors were formed when as many as 5 X 10(6) NIH/3T3 cells were applied to the membrane. NIH/3T3 cells transformed by the Abelson leukemia virus or the Moloney sarcoma virus also ivaded the CAM and formed tumors of proliferating cells within the mesoderm, while cells infected with the Moloney leukemia virus did not. NIH/3T3 cells inoculated onto the CAM 8 days after infection and transformation with KiSV formed tumors with a frequency similar to that of KiSV transformed cells that have been passaged in culture for many generations. Cells that formed invasive tumors within the mesoderm also attracted loops of host blood vessels.


Cell | 1977

Abelson virus-transformed lymphocytes: Null cells that modulate H-2

Diane McMahon Pratt; Jack L. Strominger; Robertson Parkman; David L. Kaplan; Jerrold Schwaber; Naomi Rosenberg; Charles D. Scher

A-MuLV-transformed lymphoid cells from Balb/c mice had the properties of null lymphocytes. They did not secrete Ig and all but one did not have detectable cell-associated Ig; one line synthesized, but did not secrete, the mu chain of IgM. The cells expressed H-2D and H-2K, but not H-21 histocompatibility antigens or theta-antigen; they had Fc receptors. Most cell lines grew to form donor cell tumors after inoculation into (Balb/c X C57B1/6)F1 mice. The tumor cells have more H-2Dd than cells passaged in vitro. Cell lines carried in vitro progressively lost H-2Dd. A line in which 5-30% of the cells were lysable by anti-H-2Dd was cloned; all eleven clones had H-2Dd (13-69% lysable) demonstrating that H-2 modulates in vitro. A clone with little H-2Dd (10-15% lysable) was tumorigenic even after treatment with anti-H-2Dd sera; at least 50% of the tumor cells were lysed by anti-H-2Dd. Thus A-MuLV-transformed lymphocytes modulate H-2 in vivo to higher levels and in vitro to lower levels.


Biochimica et Biophysica Acta | 1979

Uncoupling of RNA and DNA synthesis after plasma stimulation of G0-arrested Balbc-3T3 cells

Herbert T Abelson; Harry N. Antoniades; Charles D. Scher

The addition of whole serum to G0-arrested, confluent Balb/c-3T3 cells induces them to progress through G1 and synthesize DNA after a 12-h lag period. Prior to the onset of DNA synthesis, RNA is synthesized and RNA content increases. Serum has been fractionated into two sets of growth factors: a platelet-derived growth factor present in heat-treated (100 degrees C) platelet extracts and platelet-poor plasma. Addition of whole serum, platelet-derived growth factor or platelet-poor plasma induces quiescent cells to increase their cytoplasmic RNA content, but the cells treated with platelet-poor plasma do not synthesize DNA. Messenger RNA content increases within 2 h after stimulation with whole serum or platelet-poor plasma, and after 18 h, mRNA has accumulated to a greater degree than rRNA.


Proceedings of the National Academy of Sciences of the United States of America | 1979

Dual control of cell growth by somatomedins and platelet-derived growth factor.

Charles D. Stiles; G T Capone; Charles D. Scher; Harry N. Antoniades; J J Van Wyk; W. J. Pledger


Proceedings of the National Academy of Sciences of the United States of America | 1977

Induction of DNA synthesis in BALB/c 3T3 cells by serum components: Reevaluation of the commitment process

W. J. Pledger; Charles D. Stiles; Harry N. Antoniades; Charles D. Scher


Proceedings of the National Academy of Sciences of the United States of America | 1979

Purification of human platelet-derived growth factor

Harry N. Antoniades; Charles D. Scher; Charles D. Stiles


Proceedings of the National Academy of Sciences of the United States of America | 1978

An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis

W. J. Pledger; Charles D. Stiles; Harry N. Antoniades; Charles D. Scher


Blood | 1979

Platelet alpha granules contain a growth factor for fibroblasts.

David R. Kaplan; Francis C. Chao; Charles D. Stiles; Harry N. Antoniades; Charles D. Scher

Collaboration


Dive into the Charles D. Scher's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

W. J. Pledger

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Naomi Rosenberg

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Helene S. Smith

California Pacific Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. G. Martin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robertson Parkman

Children's Hospital Los Angeles

View shared research outputs
Researchain Logo
Decentralizing Knowledge